Ascential Medical & Life Sciences Appoints Vinod Mirchandani as Chief Technology Officer
Ascential Medical & Life Sciences Appoints Vinod Mirchandani as Chief Technology Officer
With robust leadership and operational experience, Vinod will develop and deploy a technology strategy to drive customer success and company growth
擁有強大的領導能力和操作經驗。eVinod將制定和實施一項科技策略，以推動客戶成功和公司增長。
SAN DIEGO, June 20, 2024 /PRNewswire/ -- Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical & life science devices that provides total commercialization services from ideation to scaled manufacturing, announced today the appointment of Vinod Mirchandani as Chief Technology Officer (CTO). Vinod joins Ascential from Thermo Fisher Scientific, where he helped transform the company's R&D organization, driving technological innovation within the healthcare industry.
2024年6月20日，美國新聞通訊社-昇華醫療生命科學（Ascential Medical & Life Sciences），是一家提供從構思到規模製造的複雜醫療生命科學設備的全流程商業化解決方案的領導者，宣佈任命文諾德·米爾欽達尼爲首席技術官（CTO）。 Vinod是從賽默飛世爾科技離職後加入昇華的，他曾幫助改造公司的研發組織，在醫療保健行業推動技術創新。
"Vinod's proven track record of leading transformative technology initiatives makes him an ideal fit for Ascential," said Anupam Girdhar, divisional CEO of Ascential Medical & Life Sciences. "His deep understanding of healthcare's rapidly evolving technology landscape, combined with his passion for innovation and customer-centric solutions, aligns perfectly with our mission to harness science and technology to save lives."
“Vinod在領導變革性技術倡議方面經驗豐富，是昇華的理想人選，” Ascential Medical & Life Sciences的分部CEO Anupam Girdhar表示。 “他對醫療保健行業快速發展的技術景觀有着深刻的了解，再加上他對創新和客戶中心解決方案的熱情，完全符合我們利用科學和技術拯救生命的使命。”
As CTO, Vinod will work closely with the executive team to identify emerging trends and leverage technology to enhance the company's ability to tackle the most challenging problems where the cost of failure is high. He will strengthen Ascential's capabilities to support customers with improved workflows, reduced costs and increased speed to market. Additionally, Vinod will play a pivotal role in fostering a culture of innovation and collaboration across the organization.
作爲首席技術官，Vinod將與高管團隊密切合作，確定出現的趨勢及利用技術提高公司應對成本高的最具挑戰問題的能力。他將加強昇華支持客戶改進工作流程，降低成本和加快上市速度的能力。此外，Vinod還將在全組織中推動創新和協作文化的重要作用。
Vinod holds a Master of Science degree in Mechanical Engineering from Stanford University and Master of Science degree in Technology Management from NTU. His distinguished career spans more than 40 years, with progressive roles in research and development (R&D) at renowned companies such as Xerox, Applied Biosystems, Johnson & Johnson, and most recently, Thermo Fisher Scientific. Vinod spent 18 years at Thermo Fisher Scientific, where he served as vice president of internal innovation and supported the Chief Scientific Officer to promote internal innovation and collaboration efforts. Prior to that, he was vice president of R&D, leading all facets of R&D for qPCR, Capillary Electrophoresis, MicroArray and Next Gen Sequencing platforms.
Vinod擁有斯坦福大學機械工程碩士學位和NTU技術管理碩士學位。他卓越的職業生涯跨越了40多年，在施樂，應用生物系統，強生和最近的賽默飛世爾科學等知名公司的研究開發部門擔任了進步角色。 Vinod在賽默飛世爾科學工作了18年，擔任過內部創新的副總裁，並支持首席科學官推廣內部創新和協作努力。在此之前，他擔任研發副總裁，領導qPCR，毛細管電泳，MicroArray和Next Gen測序平台的所有方面。
"I look forward to collaborating with colleagues and customers to identify and address technology opportunities and further strengthen our overall value proposition," said Vinod. "The accomplished Ascential Medical & Life Sciences team has a proven track record for customer satisfaction and success and is well-positioned to continue providing unparalleled, end-to-end contract development and manufacturing solutions."
“我期待與同事和客戶合作，確定和解決技術機遇，並進一步增強我們的整體價值主張，” Vinod說。 “昇華醫療和生命科學團隊的成功和客戶滿意度創紀錄，處於不斷髮展的行業裏，位置尤爲重要，我們有備無患提供出色的端到端合同開發和製造解決方案。”
"Vinod's experience and accomplishments at Thermo Fisher Scientific and beyond speak for themselves. Not only does he have the technical skills for the role, but he also has the management and organizational experience needed to implement processes, initiatives and strategy across the company," said Jeff Moss, CEO of Ascential Technologies. "As we take our technology roadmap to the next level under his direction, we will continue to prove why we are the partner of choice for our customers."
“Vinod在賽默飛世爾科學和其他領域的經驗和成就證明了他自己的能力，”昇華科技首席執行官Jeff Moss說。“他不僅擁有該職位的技術技能，還具有實施公司跨部門流程，倡議和戰略所需的管理和組織經驗。在他的領導下，我們將把我們的技術路線圖提升到更高的水平，繼續證明我們是客戶的選擇合作伙伴。”
About Ascential Medical & Life Sciences
Ascential Medical & Life Sciences designs, develops, and automates complex products from ideation to scaled manufacturing, tackling customers' most demanding, mission-critical challenges where the cost of failure is high. With more than 70 years of end-to-end innovation experience, Ascential brings together D&K Engineering, Korvis, NACS, Kinematic Automation, Aspect Automation, Quantum 3, and Primatics under its umbrella. The company helps customers accelerate critical solution innovation, mitigate risk, drive competitive differentiation, and shorten time to market, at scale. Ascential's uniqueness lies in its commitment to guiding customers through the entire product life cycle, from ideation to commercialization, where quality and safety matter most. Ascential customers include Fortune 100 leaders and disruptive innovators such as 3M, Abbott, Boston Scientific, Medtronic, and Thermo Fisher Scientific. Learn more at ascentialtech.com/mls/.
關於昇華醫療和生命科學
Ascential Medical & Life Sciences從構思到規模製造、設計、開發和自動化複雜產品，解決成本高而具挑戰性的客戶問題。擁有70多年的端到端創新經驗，昇華將D&K Engineering，Korvis，NACS，Kinematic Automation，Aspect Automation，Quantum 3和Primatics集於一體。公司幫助客戶加速關鍵解決方案的創新，降低風險，推動競爭差異化，縮短市場交付時間，大規模運作。昇華的獨特之處在於其致力於從構思到商業化的整個產品生命週期，最爲關注品質和安全。昇華的客戶包括3M，阿伯特，波士頓科學，美敦力和賽默飛世爾科學等財富100強企業和顛覆性創新者。了解更多：ascentialtech.com/mls/。
SOURCE Ascential Medical & Life Sciences
資料來源: 昇華醫療和生命科學
譯文內容由第三人軟體翻譯。